At what point does polypharmacy create too much signal noise to clearly attribute risk or benefit to any single compound?
Stacking complicates attribution of abnormal markers
Baseline disappears when many compounds overlap
Too many levers confound clean conclusions
Bloodwork reflects stack not single agents
Isolation phases help pinpoint problematic markers
Stacks mask which compound drives changes
Simpler protocols yield clearer lab insights
Context matters more with heavier stacking
It’s harder to pinpoint problem markers
Too much at once confuses labs
Labs get messy with big stacks
Too many signals not enough answers
